{
    "id": "5d387098a1e1595105000006",
    "question": "Is the tyrosine kinase BTK implicated in autoimmunity?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the provided documents to determine if the tyrosine kinase BTK is implicated in autoimmunity. According to Document [15], BTK is required for B cell development and function, and its mutation leads to X-linked agammaglobulinemia, a condition characterized by a profound defect in B cell development and function. However, this does not necessarily imply a direct link to autoimmunity. On the other hand, Document [24] mentions that B cell immunodeficiency caused by an absence of the B cell receptor-associated kinase (Bruton's tyrosine kinase) leads to X-linked agammaglobulinemia, which can predispose to autoimmunity due to altered B cell selection and survival of autoreactive B cells. Furthermore, Document [27] lists genes implicated in autoimmune disease, including those affecting cytokine signaling and regulatory T cells, which may be related to BTK's role in B cell development and function. However, Document [22] explicitly states that BTK is not mentioned as a gene that affects tolerance mechanisms, such as apoptosis, cytokine expression, or co-stimulatory molecules, which are common causes of autoimmunity. Therefore, based on the available information, we cannot conclude that BTK is directly implicated in autoimmunity. However, the lack of a clear exclusion also means that BTK is not explicitly stated to be safe from implication in autoimmunity.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "Immunology_Janeway_1717",
            "title": "Immunology_Janeway",
            "content": "in signaling by the receptor. Instead, pre-B-cell receptors are thought to interact with each other, forming dimers or oligomers that generate signals as described in Section 7-16. Dimerization involves \u2018unique\u2019 regions in the amino termini of \u03bb5 and VpreB proteins that are not present in other immunoglobulin-like domains and which mediate the cross-linking of adjacent pre-B-cell receptors on the cell surface (Fig. 8.6). PreB-cell receptor signaling requires the scaffold protein BLNK and Bruton\u2019s tyrosine kinase (Btk), an intracellular Tec-family tyrosine kinase (see Section 7-20). In humans and mice, deficiency of BLNK leads to a block in B-cell development at the pro-B-cell stage. In humans, mutations in the BTK gene cause a profound B-lineage-specific immune deficiency, Bruton\u2019s X-linked agammaglobulinemia (XLA), in which no mature B cells are produced. The block in B-cell development caused by mutations in BTK is almost total, interrupting the transition from pre-B cell to"
        },
        {
            "id": "Immunology_Janeway_4849",
            "title": "Immunology_Janeway",
            "content": "xid See X-linked immunodeficiency. X-linked agammaglobulinemia (XLA) A genetic disorder in which B-cell development is arrested at the pre-B-cell stage and no mature B cells or antibodies are formed. The disease is due to a defect in the gene encoding the protein tyrosine kinase Btk, which is encoded on the X chromosome. X-linked hyper IgM syndrome See CD40 ligand deficiency. A syndrome with some features resembling hyper IgM syndrome. It is caused by mutations in the protein NEMO, a component of the NF\u03baB signaling pathway. Also called NEMO deficiency. X-linked immunodeficiency An immunodeficiency disease in mice due to defects in the protein tyrosine kinase Btk. Shares the gene defect with X-linked agammaglobulinemia in humans, but leads to a milder B cell defect than seen in the human disease."
        },
        {
            "id": "Immunology_Janeway_1596",
            "title": "Immunology_Janeway",
            "content": "Once activated, Syk phosphorylates the scaffold protein SLP-65 (also known as BLNK). Like LAT and SLP-76 in T cells, SLP-65 functions as a composite of these two proteins, providing multiple sites for tyrosine phosphorylation and recruiting a variety of SH2-containing proteins, including enzymes and adaptor proteins, to form several distinct multiprotein signaling complexes that can act in concert. As in T cells, a key signaling protein is the phospholipase PLC-\u03b3, which is activated with the aid of the B cell-specific Tec kinase Bruton\u2019s tyrosine kinase (Btk) and hydrolyzes PIP2 to form DAG and IP3 (see Fig. 7.27). As discussed for the T-cell receptor, signaling by calcium and DAG leads to the activation of downstream transcription factors. A deficiency in Btk (which is encoded by a gene on the X chromosome) prevents the development and functioning of B cells, resulting in the disease X-linked agammaglobulinemia, which is characterized by a lack of antibodies. Besides Btk, mutations"
        },
        {
            "id": "Immunology_Janeway_3101",
            "title": "Immunology_Janeway",
            "content": "The defective gene in XLA encodes a protein tyrosine kinase called BTK (Bruton\u2019s tyrosine kinase), which is a member of the Tec family of kinases that transduce signals through the preBcell receptor (preBCR; see Section 720). As discussed in Section 83, the preBcell receptor is composed of successfully rearranged \u03bc heavy chains complexed with the surrogate light chain composed of \u03bb5 and VpreB, and with the signaltransducing subunits Ig\u03b1 and Ig\u03b2. Stimulation of the preBcellreceptor recruits cytoplasmic proteins, including BTK, which convey signals required for the proliferation and differentiation of preB cells. In the absence of BTK function, Bcell maturation is largely arrested at the preBcell stage (see Fig. 13.2; see also Section 83), resulting in profound Bcell deficiency and agammaglobulinemia. Some B cells do mature, however, perhaps as a result of compensation by other Tec kinases."
        },
        {
            "id": "Immunology_Janeway_3107",
            "title": "Immunology_Janeway",
            "content": "in X-linked agammaglobulinemia (Xla), a protein tyrosine kinase of the tec family called BtK, which is encoded on the X chromosome, is defective. in normal individuals, B-cell development proceeds through a stage in which the pre-B-cell receptor, consisting of \u03bc\u03bb5:VpreB (see Section 8-3), transduces a signal via BtK, triggering further B-cell development. in males with Xla, no signal can be transduced and, although the pre-B-cell receptor is expressed, the B cells develop no further. in female mammals, including humans, one of the two X chromosomes in each cell is permanently inactivated early in development. Because the choice of which chromosome to inactivate is random, half of the pre-B cells in a carrier female will have inactivated the chromosome with the wild-type BTK gene, meaning that they can express only the defective BTK gene and cannot develop further. therefore, in the carrier, mature B cells always have the nondefective X chromosome active. this is in sharp contrast to"
        },
        {
            "id": "Pathology_Robbins_994",
            "title": "Pathology_Robbins",
            "content": "It is one of the more common forms of primary immunodeficiency, occurring at a frequency of about 1 in 100,000 male infants. During normal B-cell maturation, immunoglobulin (Ig) heavy chain genes are rearranged first, followed by light chain genes. At each stage, signals are received from the expressed components of the antigen receptor that drive maturation to the next stage; these signals act as quality controls, to ensure that the correct receptor proteins are being produced. In XLA, B-cell maturation stops after the initial heavy chain gene rearrangement because of mutations in a tyrosine kinase that is associated with the pre\u2013B-cell receptor and is involved in pre-B-cell signal transduction. This kinase is called Bruton tyrosine kinase (BTK). When BTK is nonfunctional, the pre\u2013 B-cell receptor cannot signal the cells to proceed along the maturation pathway. As a result, Ig light chains are not produced, and the complete Ig molecule containing heavy and light chains cannot be"
        },
        {
            "id": "Immunology_Janeway_4592",
            "title": "Immunology_Janeway",
            "content": "bronchus-associated lymphoid tissue (BALT) Organized lymphoid tissue found in the bronchi in some animals. Adult humans do not normally have such organized lymphoid tissue in the respiratory tract, but it may be present in some infants and children. Bruton\u2019s tyrosine kinase (Btk) A Tec-family tyrosine kinase important in B-cell receptor signaling. Btk is mutated in the human immunodeficiency disease X-linked agammaglobulinemia. Bruton\u2019s X-linked agammaglobulinemia See X-linked agammaglobulinemia. bursa of Fabricius Lymphoid organ associated with the gut that is the site of B-cell development in chickens. butyrate A short chain fatty acid produced abundantly by anaerobic digestion of carbohydrates in the intestine by commensals that can in\ufb02uence host cells in several ways, acting as an energy source for enterocytes and as an inhibitor of histone deacetylases."
        },
        {
            "id": "Immunology_Janeway_1600",
            "title": "Immunology_Janeway",
            "content": "recruit and activate the tyrosine kinase Syk, which functions similarly to Zap-70 in T cells. The phosphorylated tail of cd19 recruits pi 3-kinase, leading to pip3 generation in the plasma membrane. activated Syk phosphorylates the membrane-associated scaffold protein SLp-65, which associates with the plasma membrane by binding cin85. pip3 recruits pdK1 and akt, leading to akt activation. phosphorylated SLp-65 and pip3 recruit the Tec-family tyrosine kinase Btk and pLc-\u03b3, leading to Btk phosphorylation and activation of pLc-\u03b3. phosphorylated SLp-65 and pip3 also recruit vav, nck, and inactive WaSp. vav activates small GTpases that activate WaSp, leading to actin polymerization; the activated GTpases also induce integrin aggregation and conversion of Lfa-1 to the high-affinity binding state."
        },
        {
            "id": "Immunology_Janeway_1597",
            "title": "Immunology_Janeway",
            "content": "on the X chromosome) prevents the development and functioning of B cells, resulting in the disease X-linked agammaglobulinemia, which is characterized by a lack of antibodies. Besides Btk, mutations in other signaling molecules in B cells, including receptor chains and SLP-65, have been linked to B-cell immunodeficiencies (see Chapter 8)."
        },
        {
            "id": "InternalMed_Harrison_24871",
            "title": "InternalMed_Harrison",
            "content": "2114 Signal transduction is initiated through the action of a Src family\u2013 related tyrosine kinase termed Lyn that is constitutively associated with the \u03b2 chain. Lyn transphosphorylates the canonical immunoreceptor tyrosine-based activation motifs (ITAMs) of the \u03b2 and \u03b3 chains of the receptor, resulting in recruitment of more active Lyn to the \u03b2 chain and of Syk tyrosine kinase. The phosphorylated tyrosines in the ITAMs function as binding sites for the tandem src homology two (SH2) domains within Syk. Syk activates not only phospholipase C\u03b3, which associates with the linker of activated T cells at the plasma membrane, but also phosphatidylinositol 3-kinase to provide phosphatidylinositol-3,4,5-trisphosphate, which allows membrane targeting of the Tec family kinase Btk and its activation by Lyn. In addition, the Src family tyrosine kinase Fyn becomes activated after aggregation of IgE receptors and phosphorylates the adapter protein Gab2 that enhances activation of phosphatidylinositol"
        },
        {
            "id": "Immunology_Janeway_3102",
            "title": "Immunology_Janeway",
            "content": "During embryonic development, females randomly inactivate one of their two X chromosomes. Because BTK is required for Blymphocyte development, only cells in which the normal allele of BTK is active develop into mature B cells. Thus, in all B cells in female carriers of a mutant BTK gene, the active X chromosome is the normal one and the abnormal X chromosome is inactivated. This fact allowed female carriers of XLA to be identified even before the nature of the BTK protein was known. In contrast, the active X chromosomes in the T cells and macrophages of carriers are an equal mixture of normal and BTK mutant X chromosomes. Nonrandom Xinactivation only in B cells shows conclusively that the BTK gene is required for the development of B cells but not the other cell types, and that BTK must act in the B cells themselves rather than in stromal or other cells required for Bcell development (Fig. 13.4)."
        },
        {
            "id": "Immunology_Janeway_1517",
            "title": "Immunology_Janeway",
            "content": "Fig. 7.9 ITAMs recruit signaling proteins that have tandem SH2 domains. The iTams of the T-cell receptor (TcR) and B-cell receptor (BcR) contain tyrosine residues within the motif`\u2026yXX[L/i] X6\u20139yXX[L/i]\u2026. The spacing between the tyrosines is important in binding to tandem Sh2-containing proteins such as Syk and Zap-70. Left panel: prior to TcR or BcR stimulation, these kinases are in an inactive conformation, known as the autoinhibited conformation. The autoinhibited conformation is stabilized by interactions between the tandem Sh2 domain-kinase domain linker region and the kinase domain that hold the enzyme in a catalytically inactive state. Right panel: after phosphorylation of both tyrosines within one iTam (here depicted as two tyrosines separated by 9-12 amino acids), the tandem Sh2 domains of Syk or Zap-70 can dock cooperatively to both phosphotyrosines, as shown here for Zap-70. By being recruited into the active signaling complex, Zap-70 can itself be phosphorylated, so that"
        },
        {
            "id": "Immunology_Janeway_1663",
            "title": "Immunology_Janeway",
            "content": "Iwashima, M., Irving, B.A., van Oers, N.S., Chan, A.C., and Weiss, A.: Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 1994, 263:1136\u20131139. Okkenhaug, K., and Vanhaesebroeck, B.: PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 2003, 3:317\u2013330. Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R.P., and Samelson, L.E.: LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998, 92:83\u201392. 7-10 Phosphorylated ITAMs recruit and activate the tyrosine kinase ZAP-70. Yan, Q., Barros, T., Visperas, P.R., Deindl, S., Kadlecek, T.A., Weiss, A., and Kuriyan, J.: Structural basis for activation of ZAP-70 by phosphorylation of the SH2-kinase linker. Mol. Cell. Biol. 2013, 33:2188\u20132201. 7-11 ITAMs are also found in other receptors on leukocytes that signal for cell activation."
        },
        {
            "id": "Immunology_Janeway_1530",
            "title": "Immunology_Janeway",
            "content": "and to attenuate TCR signaling. Dephosphorylation of the tyrosine or engagement of the SH2 or SH3 domains by their ligands releases Lck from its inactive conformation, resulting in a primed, but not fully active, Lck kinase (see Fig. 7.12). Full activation of catalytic activity also requires Lck autophosphorylation of a tyrosine in its kinase domain. In nonstimulated lymphocytes, phosphorylation of Lck is counteracted by the tyrosine phosphatase CD45, which can dephosphorylate both of the Lck tyrosine phosphorylation sites. Prior to TCR stimulation, multiple phosphorylated species of Lck are found in T cells, but antigen receptor stimulation is required to stabilize the activated form of Lck and lead to ITAM phosphorylation."
        },
        {
            "id": "Immunology_Janeway_1594",
            "title": "Immunology_Janeway",
            "content": "Fig. 7.26 Src-family kinases are associated with B-cell receptors and phosphorylate the tyrosines in ITAMs to create binding sites for Syk and Syk activation via transphosphorylation. The membrane-bound Src-family kinases fyn, Blk, and Lyn associate with the B-cell antigen receptor by binding to iTams, either (as shown in the figure) through their amino-terminal domains or by binding a single phosphorylated tyrosine through their Sh2 domains. after ligand binding and receptor clustering, the associated kinases phosphorylate tyrosines in the iTams on the cytoplasmic tails of ig\u03b1 and ig\u03b2. Subsequently, Syk binds to the phosphorylated iTams of the ig\u03b2 chain. Because there are at least two receptor complexes in each cluster, Syk molecules become bound in close proximity and can activate each other by transphosphorylation, thus initiating further signaling."
        },
        {
            "id": "InternalMed_Harrison_24827",
            "title": "InternalMed_Harrison",
            "content": "agammaglobulinemia Agammaglobulinemia is characterized by a profounddefectinBcelldevelopment(<1%ofthenormalBcellblood count). In most patients, very low residual Ig isotypes can be detected in the serum. In 85% of cases, agammaglobulinemia is caused by a mutation in the BTK gene that is located on the X chromosome. The BTK gene product is a kinase that participates in (pre) B cell receptor signaling. When the kinase is defective, there is a block (albeit a leaky one) at the pre-B to B cell stage (Fig. 374-4). Detection of BTK by intracellular immunofluorescence of monocytes, and lack thereof in patients with X-linked agammaglobulinemia, is a useful diagnostic test. Not all of the mutations in BTK result in agammaglobulinemia, since some patients have a milder form of hypogammaglobulinemia and low but detectable B cell counts. These cases should not be confused with common variable immunodeficiency (CVID, see below). About 10% of agammaglobulinemia cases are caused by alterations in"
        },
        {
            "id": "Immunology_Janeway_1718",
            "title": "Immunology_Janeway",
            "content": "X-linked agammaglobulinemia (XLA), in which no mature B cells are produced. The block in B-cell development caused by mutations in BTK is almost total, interrupting the transition from pre-B cell to immature B cell. A similar, but less severe, defect called X-linked immunodeficiency, or xid, arises from mutations in the Btk gene in mice."
        },
        {
            "id": "Cell_Biology_Alberts_6746",
            "title": "Cell_Biology_Alberts",
            "content": "Antigen binding to BCRs or TCRs clusters these receptors and their associated invariant chains (and CD4 or CD8 co-receptors in the case of TCRs). This clustering activates a Src family cytoplasmic tyrosine kinase to phosphorylate tyro-sines on the cytoplasmic tails of some of the invariant chains. The phosphotyrosines then serve as docking sites for a second cytoplasmic tyrosine kinase, which becomes phosphorylated and activated by the first kinase; the second kinase then relays the signal downstream by phosphorylating other intracellular signaling proteins on tyrosines. Some of these early events in the signaling pathway activated by BCRs are shown in Figure 24\u201346."
        },
        {
            "id": "Immunology_Janeway_1463",
            "title": "Immunology_Janeway",
            "content": "Even more important to the function of mature lymphocytes are receptors that have no intrinsic enzymatic activity themselves but associate with intracellular tyrosine kinases. The antigen receptors on B lymphocytes and T lymphocytes are of this type, as are the receptors for some types of cytokines. Ligand binding to the extracellular domain of such receptors causes particular amino acid residues in their cytoplasmic domains to become phosphorylated by specific cytoplasmic tyrosine kinases (see Fig. 7.1, bottom panel). These nonreceptor kinases either can be constitutively associated with the cytoplasmic domains of the receptors, as with many cytokine receptors, or may become associated with the receptors when they bind their ligands, as is the case for the antigen receptors."
        },
        {
            "id": "Cell_Biology_Alberts_6764",
            "title": "Cell_Biology_Alberts",
            "content": "What initiates an autoimmune disease such as type 1 diabetes or multiple sclerosis? When a na\u00efve or memory T or B cell is activated by antigen and co-stimulatory signals, how does it decide whether to become an effector cell or memory cell? Are there cells that are pre-committed to becoming either effector or memory cells, for example, or is the decision determined solely by extracellular signals? Why do some of us make Ige antibodies against harmless antigens and thereby develop hay fever and allergic asthma, while most of us do not, and why is the proportion of such allergic individuals increasing? how does a cytotoxic T cell (or NK cell) avoid being killed by the perforin and granzymes that it secretes to kill a target cell?"
        },
        {
            "id": "Immunology_Janeway_3145",
            "title": "Immunology_Janeway",
            "content": "Fig.13.10 X-linked lymphoproliferative disease (XLP) is caused by inherited defects in SAP and XIAP, resulting in abnormal SLAM and TNF family receptor signaling, respectively. SlaM is an immune receptor family, members of which are expressed by t cells, B cells, natural killer (nK) cells, dendritic cells, and macrophages. Signaling is initiated via homotypic or heterotypic interactions between family members. SlaM signaling recruits the Src homology 2 (SH2) domain-containing factor SaP, which recognizes tyrosine-based motifs in the cytoplasmic domain of SlaM to activate the Src-related tyrosine kinase Fyn (left upper panel). Fyn then phosphorylates additional tyrosine residues of SlaM to recruit additional signaling components. Mutation in SaP in patients with XlP1 (right upper panel) disrupts activation of Fyn and SlaM signaling, thereby impairing tand nK-cell cytotoxicity, which results in severe epstein\u2013Barr virus (eBV) infections and lymphoma. Defective SlaM signaling also"
        },
        {
            "id": "InternalMed_Harrison_25004",
            "title": "InternalMed_Harrison",
            "content": "Primary alterations in the activity of T and/or B cells, cytokine imbalances, or defective immunoregulatory circuits may also contribute to the emergence of autoimmunity. Diminished production of tumor necrosis factor (TNF) and interleukin (IL) 10 has been reported to be associated with the development of autoimmunity. Overproduction or therapeutic administration of type 1 interferon has also been associated with autoimmunity. Overexpression of costimulatory molecules on T cells similarly can lead to autoantibody production."
        },
        {
            "id": "Immunology_Janeway_3854",
            "title": "Immunology_Janeway",
            "content": "in an exaggerated immune response with the side effect of autoimmunity. Additionally, mutations that affect the expression or signaling of cytokines and co-stimulatory molecules have been linked to autoimmunity. A final subset comprises mutations effecting Treg-cell development or function, such as FoxP3 mutations (see Section 15-21)."
        },
        {
            "id": "InternalMed_Harrison_24576",
            "title": "InternalMed_Harrison",
            "content": "FIGUrE 372e-8 B cell receptor (BCR) activation results in the sequential activation of protein tyrosine kinases, which results in the formation of a signaling complex and activation of downstream pathways as shown. Whereas SLP76 is recruited to the membrane through GADS and LAT, the mechanism of SLP65 recruitment is unclear. Studies have indicated two mechanisms: (a) direct binding by the SH2 domain of SLP65 to immunoglobulin (Ig) of the BCR complex or (b) membrane recruitment through a leucine zipper in the amino terminus of SLP65 and an unknown binding partner. ADAP, adhesionand degranulation-promoting adaptor protein; AP1, activator protein 1; BTK, Bruton\u2019s tyrosine kinase; DAG, diacylglycerol; GRB2, growth factor receptor-bound protein 2; HPK1, hematopoietic progenitor kinase 1; InsP3, inositol-1,4,5-trisphosphate; ITK, interleukin-2-inducible T cell kinase; NCK, noncatalytic region of tyrosine kinase; NF-B, nuclear factor B; PKC, protein kinase C; PLC, phospholipase C;"
        },
        {
            "id": "InternalMed_Harrison_25002",
            "title": "InternalMed_Harrison",
            "content": "of nonpathogenic IgM auto-antibodies to the production of pathogenic IgG autoantibodies in the absence of antigen-specific T cell help. Aberrant selection of the B or T cell repertoire at the time of antigen receptor expression can also predispose to autoimmunity. For example, B cell immunodeficiency caused by an absence of the B cell receptor\u2013associated kinase (Bruton\u2019s tyrosine kinase) leads to X-linked agammaglobulinemia. This syndrome is characterized by reduced B cell numbers. This leads to high levels of BAFF which alter B cell selection and lead to greater survival of autoreactive B cells. Likewise, negative selection of autoreactive T cells in the thymus requires expression of the autoimmune regulator (AIRE) gene that enables the expression of tissue-specific proteins in thymic medullary epithelial cells. Peptides from these proteins are expressed in the context of major histocompatibility complex (MHC) molecules and mediate the central deletion of autoreactive T cells. The"
        },
        {
            "id": "Pathology_Robbins_995",
            "title": "Pathology_Robbins",
            "content": "receptor cannot signal the cells to proceed along the maturation pathway. As a result, Ig light chains are not produced, and the complete Ig molecule containing heavy and light chains cannot be assembled and transported to the cell membrane, although free heavy chains can be found in the cytoplasm. Because the BTK gene is on the X chromosome, the disorder is only seen in males. Sporadic cases with the same features have been described in females, possibly due to mutations in other genes that function in the same pathway."
        },
        {
            "id": "Pediatrics_Nelson_1641",
            "title": "Pediatrics_Nelson",
            "content": "Available @ StudentConsult.com Disorders of B cells result in an increased susceptibility to infections by encapsulated bacteria. Agammaglobulinemia results from the absence or defective function of B cells with subsequent severe decrease in immunoglobulin levels and a total absence of specific antibody. X-linked agammaglobulinemia affects males and is characterized by a profound deficiency of B cells, severe hypogammaglobulinemia, and absence of lymphoid tissue (Table 73-1; see Fig. 73-1). The defect is caused by mutations in a gene encoding the tyrosine kinase Btk on chromosome Xq22 that is involved in a signaling of the pre-B-cell receptor and the B-cell antigen receptor. Autosomal recessive agammaglobulinemiaresults from a variety of defects in the pre-B-cell and B-cell antigen receptor complexes and includes mutations in the \u03bc heavy chain gene, \u03bb5, Ig\u03b1, Ig\u03b2, and BLNK. X-linked agammaglobulinemia is more common than the autosomal recessive forms."
        },
        {
            "id": "Immunology_Janeway_3839",
            "title": "Immunology_Janeway",
            "content": "Since the advent of gene knockout technology in mice (see Appendix I, Section A-35), many genes encoding immune system proteins have been experimentally disrupted. Several strains of mice that have been generated show signs of autoimmunity, including autoantibodies and infiltration of organs by T cells. The study of these mice has expanded our knowledge of the pathways that contribute to autoimmunity, and therefore their induced mutations might be candidates for identifying naturally occurring mutations. These mutations likely affect genes that encode cytokines, co-receptors, molecules involved in antigen-signaling cascades, co-stimulatory molecules, proteins involved in apoptosis, and proteins that clear antigen or antigen:antibody complexes. A number of cytokines and signaling proteins implicated in autoimmune disease are listed in Fig. 15.32. Other targeted or mutant genes with autoimmune phenotypes in mice are listed in Fig. 15.33, as are their corresponding human counterparts,"
        },
        {
            "id": "Immunology_Janeway_1649",
            "title": "Immunology_Janeway",
            "content": "While we are beginning to understand the basic circuitry of signal transduction pathways, it is important to keep in mind that we do not yet understand why these pathways are so complex. One reason might be that the signaling pathways have roles in properties such as amplification, robustness, diversity, and efficiency of signaling responses. An important goal for the future will be to understand how the design of each signaling pathway contributes to the particular quality and sensitivity needed for specific signaling responses. Questions. 7.1 True or False: antigen receptors bear intrinsic kinase activity that allows for phosphorylation of cytoplasmic proteins and subsequent downstream signaling events. 7.2 Matching: indicate whether the following receptors are receptor tyrosine kinases (RTKs), are receptor serine/ threonine kinases (RSTKs), or have no intrinsic enzymatic activity (null). A. ___ Kit B. ___ B-cell receptor C. ___ fLT3"
        },
        {
            "id": "Immunology_Janeway_1532",
            "title": "Immunology_Janeway",
            "content": "the phosphatase cd45 (not shown) releases the Sh2 domain. Binding of other ligands to the Sh3 region can facilitate release of the linker region (not shown). in this state, Lck is considered primed, but not fully activated. Lower panel: full activation of Lck catalytic activity requires autophosphorylation on the activation loop in the kinase domain. active Lck can then phosphorylate iTams in the signaling chains of the nearby T-cell receptor. Rephosphorylation of the carboxy-terminal tyrosine by the c-terminal Src kinase (csk) or loss of the Sh3 ligand returns Lck to the inactive state."
        },
        {
            "id": "Immunology_Janeway_1474",
            "title": "Immunology_Janeway",
            "content": "Tyrosine kinase-associated receptors can assemble multiprotein signaling complexes by using proteins called scaffolds and adaptors. Scaffolds and adaptors lack enzymatic activity, and they function by recruiting other proteins into a signaling complex so that interactions among these proteins can take place."
        },
        {
            "id": "Immunology_Janeway_3851",
            "title": "Immunology_Janeway",
            "content": "15-20 Many genes that predispose to autoimmunity fall into categories that affect one or more tolerance mechanisms. Many of the genes identified as predisposing to autoimmunity can be classified as affecting autoantigen availability and clearance; apoptosis; signaling thresholds; cytokine expression or signaling; co-stimulatory molecules or their receptors; or regulatory T cells (see Figs. 15.32 and 15.33)."
        }
    ],
    "scores": [
        0.03593334817090483,
        0.03161905004034965,
        0.028953637529778267,
        0.02895033697854546,
        0.028415031570371375,
        0.02736381241054138,
        0.02692695722356739,
        0.02659502343832152,
        0.024256478547703235,
        0.024074074074074074,
        0.023837679352431793,
        0.022402597402597403,
        0.020907757421283545,
        0.02075870412267471,
        0.020440157668418536,
        0.0180999180999181,
        0.01805465191932336,
        0.018043367750860437,
        0.01793966623876765,
        0.017645245800585605,
        0.017242660720921593,
        0.016807899712865046,
        0.016609706083390293,
        0.016581719334012913,
        0.016403361344537813,
        0.016391257995735608,
        0.016124871001031993,
        0.015970668655232414,
        0.01560631427888065,
        0.015156714710592541,
        0.014877236787349146,
        0.01470276008492569
    ]
}